Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10043201HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10043202HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10043203HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10043778HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10043779HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10044861HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10044862HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS10062702HBVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS30004894HIVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TVIS30013306HIVENSG00000113448.21protein_codingPDE4DNoNo5144A0A140VJR0
Q08499
TCGA Plot Options
Drug Information
GenePDE4D
DrugBank IDDB00131
Drug NameAdenosine phosphate
Target IDBE0001287
UniProt IDQ08499
Regulation Typeproduct of
PubMed IDs17088426
CitationsTerrin A, Di Benedetto G, Pertegato V, Cheung YF, Baillie G, Lynch MJ, Elvassore N, Prinz A, Herberg FW, Houslay MD, Zaccolo M: PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol. 2006 Nov 6;175(3):441-51.
GroupsApproved; Investigational; Nutraceutical; Withdrawn
Direct ClassificationPurine ribonucleoside monophosphates
SMILESNC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
PathwaysLeigh Syndrome; Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Fatty Acid Metabolism; Gentamicin Action Pathway; Pyruvate Dehydrogenase Complex Deficiency; Purine Nucleoside Phosphorylase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Clarithromycin Action Pathway; Argininosuccinic Aciduria; Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency); Hyperinsulinism-Hyperammonemia Syndrome; Butyrate Metabolism; Pyruvate Metabolism; Pentose Phosphate Pathway; Propanoate Metabolism; Glycine and Serine Metabolism; Selenoamino Acid Metabolism; Thiamine Metabolism; Oxytetracycline Action Pathway; Tetracycline Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Roxithromycin Action Pathway; Purine Metabolism; Ammonia Recycling
PharmGKBPA164744376
ChEMBLCHEMBL752